Jeffrey T. L. Smith, Managing Director at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 10,080 shares at $19.49 ($197K) on 2018-08-01, disclosed to the SEC on 2018-08-02.
Open-market sale of $197k ALDR by Managing Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.49 | 4,060 | $79K | 40.2% |
| 2 | $19.49 | 4,060 | $79K | 40.2% |
| 3 | $19.76 | 980 | $19K | 9.8% |
| 4 | $19.76 | 980 | $19K | 9.8% |
| Total | $19.54 avg | 10,080 | $197K | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |